FDA.reportPublic FDA data

epinastine hydrochloride 0.05 % Ophthalmic Solution

RxCUI
860654
RxNorm name
epinastine hydrochloride 0.05 % Ophthalmic Solution
Display name
epinastine hydrochloride 0.05 % Ophthalmic Solution
Full name
epinastine hydrochloride 0.05 % Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EPINASTINE HYDROCHLORIDEEPINASTINE HYDROCHLORIDESomerset Therapeutics, LLC0d4ee45c-e58f-4b7c-b389-898f5c27f54d2025-03-22Warnings, Adverse reactionsExact identifier
rxcui: 860654

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0d4ee45c-e58f-4b7c-b389-898f5c27f54depinastine hydrochloride 0.05 % Ophthalmic SolutionSY7These highlights do not include all the information needed to use EPINASTINE HCl safely and effectively. See full prescribing information for EPINASTINE HCl. EPINASTINE HCl Ophthalmic Solution 0.05% Initial U.S. Approval: 200320250322
0d4ee45c-e58f-4b7c-b389-898f5c27f54depinastine HCl 0.05 % Ophthalmic SolutionPSN7These highlights do not include all the information needed to use EPINASTINE HCl safely and effectively. See full prescribing information for EPINASTINE HCl. EPINASTINE HCl Ophthalmic Solution 0.05% Initial U.S. Approval: 200320250322
0d4ee45c-e58f-4b7c-b389-898f5c27f54depinastine hydrochloride 0.5 MG/ML Ophthalmic SolutionSCD7These highlights do not include all the information needed to use EPINASTINE HCl safely and effectively. See full prescribing information for EPINASTINE HCl. EPINASTINE HCl Ophthalmic Solution 0.05% Initial U.S. Approval: 200320250322
0d4ee45c-e58f-4b7c-b389-898f5c27f54depinastine hydrochloride 0.05 % (as epinastine 0.044 % ) Ophthalmic SolutionSY7These highlights do not include all the information needed to use EPINASTINE HCl safely and effectively. See full prescribing information for EPINASTINE HCl. EPINASTINE HCl Ophthalmic Solution 0.05% Initial U.S. Approval: 200320250322
cafe4650-6aa4-4466-9beb-064ee5a0e401epinastine hydrochloride 0.05 % (as epinastine 0.044 % ) Ophthalmic SolutionSY5These highlights do not include all the information needed to use EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION. EPINASTINE HYDROCHLORIDE ophthalmic solution Initial U.S. Approval: 200320181024
cafe4650-6aa4-4466-9beb-064ee5a0e401epinastine HCl 0.05 % Ophthalmic SolutionPSN5These highlights do not include all the information needed to use EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION. EPINASTINE HYDROCHLORIDE ophthalmic solution Initial U.S. Approval: 200320181024
cafe4650-6aa4-4466-9beb-064ee5a0e401epinastine hydrochloride 0.05 % Ophthalmic SolutionSY5These highlights do not include all the information needed to use EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION. EPINASTINE HYDROCHLORIDE ophthalmic solution Initial U.S. Approval: 200320181024
cafe4650-6aa4-4466-9beb-064ee5a0e401epinastine hydrochloride 0.5 MG/ML Ophthalmic SolutionSCD5These highlights do not include all the information needed to use EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for EPINASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION. EPINASTINE HYDROCHLORIDE ophthalmic solution Initial U.S. Approval: 200320181024